The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.
about
Neuropsychiatric symptoms in Alzheimer's disease: What might be associated brain circuits?Reward sensitivity deficits modulated by dopamine are associated with apathy in Parkinson’s diseaseEffects of Group, Individual, and Home Exercise in Persons With Parkinson Disease: A Randomized Clinical Trial.Trust behavior in Parkinson's disease: results of a trust game experiment.Recognition of facial and musical emotions in Parkinson's disease.Apathy, but not depression, is associated with executive dysfunction in cerebral small vessel disease.Neural basis of self-initiative in relation to apathy in a student sample.Apathy and emotion-based decision-making in amnesic mild cognitive impairment and Alzheimer's disease.Arterial spin labelling reveals prolonged arterial arrival time in idiopathic Parkinson's disease.Environmental enrichment reduces signs of boredom in caged mink.Examination of the Lille Apathy Rating Scale in Parkinson disease.How cautious should we be when assessing apathy with the Unified Parkinson's Disease Rating Scale?Improving functional disability and cognition in Parkinson disease: randomized controlled trial.Assessing neuropsychiatric symptoms in people with dementia: a systematic review of measures.Characterization of reward and effort mechanisms in apathy.Apathy and anhedonia in Parkinson's disease.Prevalence and correlates of apathy in myotonic dystrophy type 1Apathy and depression: separate factors in Parkinson's diseaseClinical correlates of apathy in patients recently diagnosed with Parkinson's disease: the ANIMO study.Dopamine enhances willingness to exert effort for reward in Parkinson's disease.Emotion and ocular responses in Parkinson's disease.An exploration of apathy and impulsivity in Parkinson disease.Nonmotor symptoms in Parkinson's disease in 2012: relevant clinical aspects.Parkinson Patients' Initial Trust in Avatars: Theory and Evidence.Improvement of gait by chronic, high doses of methylphenidate in patients with advanced Parkinson's diseaseDistinct Subtypes of Apathy Revealed by the Apathy Motivation Index.The role of cognitive effort in subjective reward devaluation and risky decision-making.Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes.Toys and gadgets: construct validity of apathy in Parkinson's disease.An fMRI study into emotional processing in Parkinson's disease: Does increased medial prefrontal activation compensate for striatal dysfunction?Components of depression in Parkinson disease.Individual Differences in Premotor Brain Systems Underlie Behavioral Apathy.Distinct roles of dopamine and subthalamic nucleus in learning and probabilistic decision makingHuman ventromedial prefrontal lesions alter incentivisation by reward.Working Memory Deficit as a Risk Factor for Severe Apathy in Schizophrenia: A 1-Year Longitudinal StudyDopamine and Consolidation of Episodic Memory: Timing is Everything.Impulsivity and apathy in Parkinson's disease.Are the available apathy measures reliable and valid? A review of the psychometric evidenceImpact of Combined Subthalamic Nucleus and Substantia Nigra Stimulation on Neuropsychiatric Symptoms in Parkinson's Disease PatientsFunctional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease.
P2860
Q26827219-4E3A4C51-FD0C-4AEC-A8B6-491CE426DA81Q27303483-7525CA72-3CD7-42E7-922A-D2D57F9AA282Q27313934-885BAB58-E6B2-42D8-A598-E96879506CD7Q30405612-E4D44B84-26D0-4407-924C-EFED2722C7B4Q30425339-71F29CCE-FAE6-413A-854D-7EBA5C0F3CD6Q33663500-254F852F-3EB1-4710-9A89-9A5C1E60ECD1Q33790185-C1C0353F-6C85-4CE6-8FA2-DA213142CBF7Q33876568-DCBE4B18-D170-49B1-8078-12D0FB6C14D0Q34432509-D6F672D2-657B-4045-B7FC-F799A48F2D1FQ34479304-E6FE05E0-DEE4-4046-ABD6-C2501BD7B079Q34610660-3BE6C2CF-74B3-419A-9B8A-BF6B662B674BQ34610681-43970E86-6A98-4C29-BC21-86A9CE9FDCBDQ34771219-ED3DAA9A-F5D4-4F4F-B8EF-0EC307B92D58Q35619443-B2EA3190-FA88-44AE-B374-BC91AEA385C1Q35673605-CE2D27DB-3796-4337-A309-0ED5F4235D37Q35687306-9A2FDA46-3270-449A-B1EB-7953DDC84668Q35752575-73AC84D7-7014-40CE-BCB1-0786A62FEFA8Q35827021-8313DA9D-D368-43DB-A0CF-370EB5AA6618Q35886708-902B29F1-5E30-4B63-BC7C-483C426B3632Q35943026-A64BEBF2-AD55-47A0-BB5B-7F737D101153Q36062512-CBB89D4E-E428-4940-8149-5CE72CC6103BQ36102120-706E4FE8-F7AF-4DB1-932B-7EF03D11DC95Q36135045-1112C957-2512-44CC-B87B-63D5114968F1Q36184457-F185FA9B-BA1C-41E6-A290-24EF60F44060Q36227392-A059EA9C-64BE-4572-9B5A-CC7C667E119DQ36246300-D6995DD9-CD6D-46C6-914D-D6F3A6BC4D8EQ36301094-DDBD9B10-1D3A-4889-9941-8445D1D918C6Q36305494-CBC7DBF8-A235-4212-8AB7-A234FEFE8856Q36326055-36888045-5DD6-444E-A21E-A2C7AA35F415Q36367029-9802F231-1B8B-4EC5-833D-DE0CA4BBCF1BQ36374392-90EE5FCA-FFCB-484E-AD75-9A7448837318Q36462420-C7B4E99A-6F82-429A-B751-812F0F09443FQ36474680-E961EF02-B412-40BF-800B-39A5F4CF37BAQ36672820-0D6AC69B-2C9C-44F6-BA77-814CF7C4A111Q36817289-BBD8A3C8-867A-427B-BE63-D2E1234455C2Q36935143-14018E5F-0013-4A75-BE3D-5F6829786D49Q37331607-ACF8B194-8693-4FFB-9B9D-A5C5990A7C2FQ37518104-220D9055-BAA1-477D-A509-BF06DCF47031Q37633170-425E895D-3C6A-49E0-B27D-8CF6967B043DQ37715886-CB9ECF62-5871-4B9C-A2FE-407226D055B2
P2860
The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
The Lille apathy rating scale ...... dation in Parkinson's disease.
@ast
The Lille apathy rating scale ...... dation in Parkinson's disease.
@en
type
label
The Lille apathy rating scale ...... dation in Parkinson's disease.
@ast
The Lille apathy rating scale ...... dation in Parkinson's disease.
@en
prefLabel
The Lille apathy rating scale ...... dation in Parkinson's disease.
@ast
The Lille apathy rating scale ...... dation in Parkinson's disease.
@en
P2093
P2860
P356
P1476
The Lille apathy rating scale ...... dation in Parkinson's disease.
@en
P2093
P2860
P304
P356
10.1136/JNNP.2005.075929
P407
P577
2006-05-01T00:00:00Z